Search

In Present Days The NLS-diagnostics By Bioplasm NLS Can Do More In Oncology

Author:Thomas  UpdateTime:2018-10-29

During last few years there was a strong development of all kinds of hardware diagnostics used in oncology. Such technologies include traditional X-ray examination with its methodic varieties (rontgenoscopy, rontgenography and others), ultrasonic diagnostics, computer tomography (CT) and magnetic resonance tomography (MRT), traditional angiography, different methods and techniques of nuclear medicine, and NLS method which is widely used in oncology with the help of Metatron system. Mutual vectors of that kind of developments are: increasing of NLS technologies hardware significance and difficulty and also individual devices; general integration of this method along with different technologies for diagnostics problems solving in the context of single anatomical region, system or pathology.

In oncology NLS diagnostic is oriented mainly for solving fundamental problems which are oncological diseases pre- revealing, their nosologic diagnostic, staging and cure results oversee. In the present days we can talk about forming of NLS-diagnostics by bioplasm nls special tendencies which are realized on various stages of oncological treatment and demand all sorts of organized, technological and technical approach. Such as:

1. Early (pre-clinical) new growths diagnostics or oncological diseases screening;

2. Pathological organs and tissue changes evaluation using noninvasive NLS-technologies;

2.1. Diagnostics and differential diagnostics of discovered pathological growths, particularly oncological and non-oncological diseases, anatomical and functional peculiar properties process determination;

2.2. Cancerous growth staging including traditional oversee of primary growth prevalence, regional lymphatic nodes metastasizes and distant metastasizes;

2.3. Results of surgical, medicinal and radiation therapy oversee, including the factual change of tumor tissue, and complication and reactions that appear in the course of healing;

2.4. Patients case monitoring after treatment.

Views:  [Printing]  [Close]    

This article is provide from [Metatron 4025 hunter],please indicate the source address reprinted:http://www.healthycarer.com/news/nls-knowledge/1563.html